Position in IMUX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,258,362
+$267,991 QoQ
Shares Held
113,366
+1.0% QoQ
Ownership
0.832%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#33
of 78 holders
Holding Since
Jun 2023
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IMUX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Virtu Financial LLC holds $51,538,389 across 141 Biotechnology names. IMUX ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
70,715 | $3,728,094 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,634 | $3,408,886 | |
| 3 | CNTA |
Centessa Pharmaceuticals plc
|
67,775 | $2,692,023 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
54,785 | $2,204,000 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
38,479 | $2,173,678 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
262,298 | $2,011,825 | |
| 7 | KALA |
KALA BIO, Inc.
|
152,197 | $1,316,504 | |
| 8 | IMUX |
Immunic, Inc.
This page
|
113,366 | $1,258,362 |
All Filings in IMUX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,258,362 | 113,366 | Shares | Defined | 2026-05-14 | |
| 2025-09-30 | $990,371 | 112,287 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $121,280 | 12,128 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $500,923 | 30,359 | Shares | Defined | 2024-11-20 | |
| 2024-03-31 | $251,961 | 19,088 | Shares | Defined | 2024-05-20 | |
| 2023-06-30 | $1,692,342 | 67,424 | Shares | Defined | 2023-07-27 | |
| No filing history on record for this holder in this stock. | ||||||